TREM2 mRNA expression in leukocytes is increased in Alzheimer's disease and schizophrenia

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Mori, Yoko ^a   Yoshino, Yuta ^a   Ochi, Shinichiro ^a   Yamazaki, Kiyohiro ^a   Kawabe, Kentaro ^a   Abe, Masao ^a   Kitano, Tomoji ^a   Ozaki, Yuki ^a   Yoshida, Taku ^a   Numata, Shusuke ^b   Mori, Takaaki ^a   Iga, Junichi ^a   Kuroda, Norio ^c   Ohmori, Tetsuro ^b   Ueno, Shu Ichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Kuroda Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); LEUKOCYTE; MALE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREM2 GENE; TYROBP GENE; CHONDRODYSPLASIA; GENETICS; LIPODYSTROPHY; METABOLISM; SUBACUTE SCLEROSING PANENCEPHALITIS; UPREGULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; LEUKOCYTES; LIPODYSTROPHY; MALE; MEMBRANE GLYCOPROTEINS; OSTEOCHONDRODYSPLASIAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SCHIZOPHRENIA; SUBACUTE SCLEROSING PANENCEPHALITIS; UP-REGULATION;

EID: 84947465878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136835     Document Type: Article

References (35)

1. Hakola HP. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl 1972; 232: 1-173. PMID: 4509294
2. Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 2002; 71: 656-662. PMID: 12080485
3. Paradowska-Gorycka A, Jurkowska M. Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12. Human Immunology 2013; 74: 730-737. doi: 10.1016/j.humimm.2013. 02.003 PMID: 23459077
4. Colonna M. DAP12 signaling: from immune cells to bone modeling and brain myelination. Journal of Clinical Investigation 2003; 111: 313-314. PMID: 12569153
5. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, Kaji M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. Journal of Clinical Investigation 2003; 111: 323-332. PMID: 12569157
6. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer's disease. The New England Journal of Medicine 2013; 368: 117-127. doi: 10.1056/ NEJMoa1211851 PMID: 23150934
7. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley W, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Molecular Neurodegeneration 2013; 8: 19. doi: 10.1186/1750-1326-8-19 PMID: 23800361
8. Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, et al. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol Aging 2013; 34: 2077.e11-18.
9. Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 2014; 71: 449-453. doi: 10. 1001/jamaneurol.2013.6237 PMID: 24535663
10. Lue L, Schmitz C, Sorrano G, Sue L, Beach T, Walker D. TREM2 protein expression changes correlate with Alzheimer's disease neurodegenerative pathologies in postmortem temporal cortices. Brain Pathol. 2015; 25(4): 469-480 doi: 10.1111/bpa.12190 PMID: 25186950
11. McKhann G, Knopman D, Chertkow H, Hyman B, Jack C, Kawas C, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2011; 7: 263-269.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198. PMID: 1202204
13. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
14. Carrol ED, Salway F, Pepper SD, Saunders E, Mankhambo LA, Ollier WE, et al. Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol. 2007; 12: 8:20. PMID: 17850649
15. Watanabe S, Iga J, Ishii K, Numata S, Shimodera S, Fujita H, et al. Biological tests for major depressive disorder that involve leukocyte gene expression assays. J Psychiatr Res. 2015; 66-67: 1-6. doi: 10. 1016/j.jpsychires.2015.03.004 PMID: 25943949
16. Hu N, Tan MS, Yu JT, Sun L, Tan L, Wang YL, et al. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J Alzheimers Dis 2014; 38: 497-501. doi: 10.3233/JAD-130854 PMID: 24002183
17. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. PMID: 11846609
18. Takahashi K, Rochford C, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. The J Exp Med. 2005; 201(4): 647-657. PMID: 15728241
19. Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, Mégarbané A. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Human Mutation 2008; 29: E194-204. doi: 10.1002/ humu.20836 PMID: 18546367
20. Neumann H, Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 2007; 184: 92-99. PMID: 17239445
21. Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiology of Disease 2005; 18: 314-322. PMID: 15686960
22. Frank S, Burbach G, Bonin M, Walter M, Streit W, Bechmann I, et al. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008; 56: 1438-1447. doi: 10.1002/ glia.20710 PMID: 18551625
23. Monji A, Kato T, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013; 42: 115-121.
24. Hickman S, Khoury J. TREM2 and the neuroimmunology of Alzheimer's disease. Biochem Pharmacol. 2014; 88(4): 495-498. doi: 10.1016/j.bcp.2013.11.021 PMID: 24355566
25. Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, et al. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol 2015; 129: 429-447. doi: 10.1007/ s00401-015-1388-1 PMID: 25631124
26. Avramopoulos D, Pearce BD, McGrath J, Wolyniec P, Wang R, Eckart N, et al. Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PloS one. 2015; doi: 10.1371/journal.pone.0116696 PMID: 25781172
27. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, et al. C-reactive protein is elevated in schizophrenia. Schizophr Res. 2013; 143(1): 198-202. doi: 10.1016/j.schres.2012.10.041 PMID: 23218564
28. Al-Hakeim HK, Al-Rammahi AD, Al-Dujaili AH. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord. 2015; doi: 10.1016/j.jad.2015.04.044 PMID: 25985379
29. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment 2011; 2011: 325789. doi: 10.1155/2011/325789 PMID: 22937264
30. Doorduin J, Vries E, Willemsen A, Groot J, Dierckx R, Klein H. Neuroinflammation in schizophreniarelated psychosis: a PET study. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2009; 50: 1801-1807.
31. Takahashi N, Sakurai T. Roles of glial cells in schizophrenia: possible targets for therapeutic approaches. Neurobiology of Disease 2013; 53: 49-60. doi: 10.1016/j.nbd.2012.11.001 PMID: 23146995
32. Daws M, Lanier L, Seaman W, Ryan J. Cloning and characterization of a novel mouse myeloid DAP12- associated receptor family. Eur J Immunol 2001; 31: 783-791. PMID: 11241283
33. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391: 703-707. PMID: 9490415
34. Masel J. Genetic drift. Curr Biol. 2011; 21(20): R837-838. doi: 10.1016/j.cub.2011.08.007 PMID: 22032182
35. Miyashita A, Wen Y, Kitamura N, Matsubara E, Kawarabayashi T, Shoji M, et al. Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population. J Alzheimers Dis 2014; 41: 1031-1038. doi: 10.3233/JAD-140225 PMID: 24762945